CION Ameerpet
MALT lymphoma is a slow-growing lymphoma that most often begins in the stomach lining, where it is closely tied to long-standing H. pylori infection. Remarkably, clearing that infection can make many early tumours regress. This guide explains how, and how CION plans your care.
MALT lymphoma is a slow-growing (indolent) non-Hodgkin lymphoma that begins in mucosa-associated lymphoid tissue — the immune tissue that lines organs such as the stomach, salivary glands, lungs, thyroid and eye. It is a B-cell lymphoma and the most common member of the marginal zone lymphoma family. To see where it sits among all the subtypes, start at our lymphoma hub.
The stomach is by far the most common site, and gastric MALT lymphoma has a striking feature that sets it apart from most cancers: it is closely tied to chronic infection with the bacterium Helicobacter pylori. In many early cases, simply eradicating that infection with antibiotic-based therapy causes the lymphoma to regress. This makes MALT lymphoma one of the few cancers where treating an infection is the first-line treatment.
Because it grows slowly, MALT lymphoma is often caught early and localised, and the outlook is generally favourable. This page explains the H. pylori link, how the disease is diagnosed and treated, and when to seek a second opinion. For treatment specifics, see Lymphoma Treatment in Hyderabad.
Gastric MALT lymphoma is one of the very few human cancers that can be treated by clearing an infection. Because chronic Helicobacter pylori infection drives the disease, eradicating the bacterium with antibiotic-based therapy leads to lymphoma regression in a large proportion of early, localised cases — making antibiotics the recommended first-line treatment. (Source: NCCN and ESMO guidelines on gastric marginal zone / MALT lymphoma.)
In the stomach, years of low-grade inflammation from an ordinary bacterium can, in a small number of people, tip lymphoid tissue over into cancer — and reversing that trigger can reverse the disease.
Long-standing H. pylori infection keeps the stomach lining inflamed for years. This constant immune stimulation causes lymphoid tissue to build up where there was none, and in some people that tissue eventually becomes a clonal lymphoma. Read the detailed pathway on our H. pylori & MALT lymphoma page.
Because the lymphoma often depends on the ongoing bacterial stimulation, clearing the infection can make it regress. In many early gastric cases this is the only treatment needed, with response confirmed on repeat endoscopy. Specific drug regimens are individualised on the Treatment page.
Not every tumour responds. Those carrying the t(11;18) translocation, disease that has spread deeper or beyond the stomach, and the minority that are H. pylori-negative usually need additional treatment such as radiation or antibody therapy. This is why molecular testing is done up front.
MALT lymphoma is the extranodal type of marginal zone lymphoma. It also belongs to the wider group of extranodal lymphomas and gastrointestinal lymphomas that begin outside the lymph nodes.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just diagnosed with gastric MALT lymphoma, want to know whether antibiotic therapy is right for you, or need a second opinion before treatment? CION's lymphoma team is here.
Because MALT lymphoma grows slowly and its symptoms overlap with common stomach problems, it can be present for a while before it is recognised. Most warning signs are the kind that also come from gastritis or an ulcer — which is exactly why diagnosis relies on endoscopy and biopsy rather than symptoms alone. Watch for:
The classic drenching night sweats and high fevers of aggressive lymphoma are uncommon in this indolent subtype. But stomach symptoms that are persistent — especially with weight loss or signs of bleeding — deserve an endoscopy. Speak to a CION lymphoma specialist if you have these signs or a confirmed diagnosis.
Confirming gastric MALT lymphoma — and deciding whether antibiotics alone can treat it — takes a step-by-step pathway. CION coordinates the endoscopy, expert haematopathology and molecular testing so the plan rests on a complete picture.
An upper GI endoscopy lets the doctor see the stomach lining directly and take several tissue samples. The pathologist examines these under the microscope and uses immunohistochemistry to confirm the B-cell nature (typically CD20-positive) and to rule out a more aggressive lymphoma such as DLBCL.
The same biopsies are checked for H. pylori, backed up by breath or stool tests. A key molecular test looks for the t(11;18) chromosomal translocation: tumours carrying it are much less likely to respond to antibiotic therapy alone, so finding it early changes the plan. The detailed biology is on our H. pylori & MALT lymphoma page.
Endoscopic ultrasound gauges how deep the lymphoma reaches in the stomach wall, while imaging such as CT or PET-CT checks whether other sites or lymph nodes are involved. Most gastric MALT lymphomas are found localised, which is one reason the outlook is good. Staging follows NCCN and ESMO guidance and guides whether antibiotics, radiation or antibody therapy is the right first step.
The plan depends on the site, the stage, H. pylori status and whether the t(11;18) translocation is present. Every case is reviewed by CION's multidisciplinary tumour board, in line with NCCN and ESMO guidance, before treatment begins. The main building blocks are:
For early, localised gastric MALT lymphoma that is H. pylori-positive, antibiotic-based eradication therapy is the recommended first-line treatment. Clearing the infection makes the lymphoma regress in a large share of patients, and this is confirmed with repeat endoscopy and biopsies over the following months. Because the specific drug combination is individualised, exact regimens are covered on our Lymphoma Treatment in Hyderabad page.
When antibiotics do not clear the lymphoma, when disease is H. pylori-negative, or for MALT lymphoma at non-gastric sites, low-dose radiation therapy (IMRT) to the involved area is highly effective for localised disease and is delivered directly at CION. It shapes the dose precisely to the affected tissue while sparing surrounding organs.
More widespread MALT lymphoma may be treated with an anti-CD20 monoclonal antibody, sometimes combined with gentle chemotherapy suited to a slow-growing lymphoma. CION's medical oncology team delivers antibody and systemic therapy directly. Choices here are guided by stage and by how the disease behaves over time.
Some people with stable, symptom-free MALT lymphoma — as with other indolent lymphomas — are suitable for careful active monitoring rather than immediate treatment, with a clear plan to step in if the disease changes. This avoids unnecessary side effects while nothing needs to be done.
MALT lymphoma is one of the more favourable lymphomas. Because it is indolent and usually found early and localised, most patients do very well, and published series report high long-term survival for gastric MALT lymphoma — generally better than the average for indolent non-Hodgkin lymphomas. As a benchmark for context, aggressive lymphomas such as DLBCL are reported at roughly 60–70% survival and Hodgkin lymphoma at around 80–90% in published series; indolent MALT lymphoma typically sits at the favourable end. Figures vary by individual, site and stage, and should be discussed with your own team rather than applied from population averages.
Two points matter for the long term. First, MALT lymphoma can relapse or, uncommonly, transform into a more aggressive lymphoma — a pattern also seen when a follicular lymphoma transforms — so periodic endoscopy and review are important. Second, if H. pylori was the driver, eradicating it also lowers the future risk. CION provides structured survivorship follow-up so any change is caught early. For the broader B-cell picture, see marginal zone lymphoma and the lymphoma hub.
MALT lymphoma involves several finely balanced decisions, and a second opinion is especially valuable in a few situations:
You can see our specialists directly — see the best lymphoma doctors in Hyderabad and the best lymphoma hospital in Hyderabad. CION offers a dedicated, free written second-opinion service — a plan built around healing, with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if H. pylori and t(11;18) testing has not yet been arranged on your biopsies.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.MALT lymphoma is a slow-growing (indolent) non-Hodgkin lymphoma that arises from mucosa-associated lymphoid tissue — the immune tissue lining organs such as the stomach, salivary glands, lungs, thyroid and eye. It belongs to the marginal zone lymphoma family, of which it is the most common type. The stomach is the single most frequent site, and gastric MALT lymphoma is strongly linked to long-standing infection with the bacterium Helicobacter pylori. Because it grows slowly, MALT lymphoma is often diagnosed at an early, localised stage and frequently responds very well to treatment. To understand where it sits among other subtypes, see our lymphoma hub.
In the stomach, chronic Helicobacter pylori infection triggers ongoing inflammation. Over years, this constant immune stimulation can drive lymphoid tissue to accumulate in the stomach lining and, in some people, evolve into gastric MALT lymphoma. The link is strong enough that most people with gastric MALT lymphoma test positive for H. pylori. The clinically important consequence is that clearing the infection with antibiotic-based therapy can, in many early cases, cause the lymphoma itself to regress. This is one of the few cancers where treating an infection is the first-line therapy. Our dedicated page on H. pylori & MALT (stomach) lymphoma explains this connection in more detail.
Gastric MALT lymphoma often causes vague, non-specific symptoms that overlap with ordinary gastritis or an ulcer — which is why it can go unrecognised for a while. Common features include persistent indigestion or upper-abdominal discomfort, a feeling of fullness after small meals, nausea, loss of appetite, and sometimes unexplained weight loss. Occasionally it causes bleeding, seen as dark stools or anaemia found on a blood test. The classic "B symptoms" of lymphoma — drenching night sweats and high fevers — are uncommon in this indolent subtype. Because these symptoms are so common and usually benign, diagnosis relies on an endoscopy with biopsies rather than symptoms alone.
For gastric MALT lymphoma, an upper GI endoscopy with multiple biopsies is the key test. A pathologist examines the tissue and uses immunohistochemistry to confirm the B-cell marker pattern (typically CD20-positive) and to exclude a more aggressive lymphoma. H. pylori is looked for on the same biopsies and with breath or stool tests. Testing for the t(11;18) chromosomal translocation helps predict whether antibiotic therapy alone is likely to work. Staging then defines how localised the disease is, using endoscopic ultrasound to gauge depth and imaging such as CT or PET-CT to check other sites. CION coordinates endoscopy, expert haematopathology and molecular testing so the plan is built on a complete picture.
In many early, localised cases of gastric MALT lymphoma, yes — eradicating Helicobacter pylori with antibiotic-based therapy leads the lymphoma to regress, and a large share of patients achieve lasting remission with this approach alone. Response is monitored with repeat endoscopy and biopsies over the following months. However, some tumours — particularly those carrying the t(11;18) translocation, those that have spread deeper or beyond the stomach, or the minority that are H. pylori-negative — do not respond to antibiotics and need additional treatment such as radiation therapy or antibody-based therapy. That is why molecular testing and careful staging matter. Outcomes vary by individual; a specialist review guides the right first step.
When antibiotic therapy fails, when the disease is H. pylori-negative, or when it involves sites outside the stomach, other options are used depending on stage. For localised disease, low-dose radiation therapy (IMRT) to the involved area is highly effective and is delivered directly at CION. More widespread disease may be treated with an anti-CD20 monoclonal antibody, with or without gentle chemotherapy, chosen for this slow-growing lymphoma. Some patients with stable, symptom-free disease are suitable for active monitoring. Specific drug regimens are individualised — see our Lymphoma Treatment in Hyderabad page. Every case at CION is reviewed by a multidisciplinary tumour board following NCCN and ESMO guidance.
MALT lymphoma is one of the more favourable lymphomas. Because it is indolent and often found early and localised, most patients do very well, and published series report high long-term survival for gastric MALT lymphoma — often well above the average for indolent non-Hodgkin lymphomas. It can relapse or, rarely, transform into a more aggressive lymphoma such as diffuse large B-cell lymphoma, so long-term follow-up with periodic endoscopy is important. Exact figures vary by individual, by site and by stage, and should be interpreted with your own team rather than applied from population averages. For living well with a slow-growing lymphoma, see living with an indolent lymphoma.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.